© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Globus Medical, Inc. (GMED) stock surged +0.32%, trading at $84.30 on NYSE, up from the previous close of $84.03. The stock opened at $83.30, fluctuating between $82.06 and $84.73 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 20, 2026 | 80.64 | 84.08 | 80.30 | 84.03 | 2.4M |
| May 19, 2026 | 79.00 | 80.31 | 77.72 | 79.93 | 2.08M |
| May 18, 2026 | 76.52 | 79.69 | 76.52 | 78.93 | 1.76M |
| May 15, 2026 | 76.93 | 77.38 | 75.89 | 76.64 | 1.37M |
| May 14, 2026 | 76.08 | 78.11 | 75.45 | 77.21 | 1.67M |
| May 13, 2026 | 75.45 | 77.14 | 74.50 | 75.57 | 1.68M |
| May 12, 2026 | 76.70 | 77.54 | 75.56 | 76.13 | 2.42M |
| May 11, 2026 | 78.98 | 80.23 | 76.64 | 76.68 | 2.63M |
| May 08, 2026 | 85.55 | 85.55 | 76.52 | 77.95 | 6.04M |
| May 07, 2026 | 90.29 | 91.44 | 84.88 | 85.07 | 2.91M |
| May 06, 2026 | 90.51 | 91.25 | 88.28 | 89.22 | 1.37M |
| May 05, 2026 | 90.57 | 91.60 | 89.51 | 90.03 | 804.5K |
| May 04, 2026 | 91.00 | 92.02 | 90.05 | 90.60 | 1.1M |
| Apr 30, 2026 | 88.57 | 90.36 | 87.50 | 90.18 | 1.01M |
| Apr 29, 2026 | 90.22 | 90.70 | 87.51 | 87.79 | 894.15K |
| Apr 28, 2026 | 93.94 | 94.20 | 90.64 | 90.74 | 706.26K |
| Apr 27, 2026 | 94.68 | 95.68 | 93.39 | 93.70 | 796.09K |
| Apr 23, 2026 | 94.50 | 95.51 | 93.39 | 94.38 | 562.06K |
| Apr 22, 2026 | 94.46 | 96.70 | 94.01 | 95.00 | 754.33K |
| Apr 21, 2026 | 96.99 | 97.39 | 93.60 | 93.83 | 1.33M |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
| Employees | 5300 |
| Beta | 1.07 |
| Sales or Revenue | $1.57B |
| 5Y Sales Change% | 0.904% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |